Chulani Karunatilake

2021

In 2021, Chulani Karunatilake earned a total compensation of $3.9M as Chief Technology Officer at Werewolf Therapeutics.

Compensation breakdown

Bonus$128,000
Option Awards$3,520,251
Salary$214,205
Other$1,226
Total$3,863,682

Karunatilake received $3.5M in option awards, accounting for 91% of the total pay in 2021.

Karunatilake also received $128K in bonus, $214.2K in salary and $1.2K in other compensation.

Rankings

In 2021, Chulani Karunatilake's compensation ranked 3,467th out of 12,415 executives tracked by ExecPay. In other words, Karunatilake earned more than 72.1% of executives.

ClassificationRankingPercentile
All
3,467
out of 12,415
72nd
Division
Manufacturing
1,416
out of 5,505
74th
Major group
Chemicals And Allied Products
572
out of 2,375
76th
Industry group
Drugs
510
out of 2,096
76th
Industry
Pharmaceutical Preparations
356
out of 1,546
77th
Source: SEC filing on April 22, 2022.

Karunatilake's colleagues

We found four more compensation records of executives who worked with Chulani Karunatilake at Werewolf Therapeutics in 2021.

2021

Daniel Hicklin

Werewolf Therapeutics

Chief Executive Officer

2021

Timothy Trost

Werewolf Therapeutics

Chief Financial Officer

2021

Randi Isaacs

Werewolf Therapeutics

Chief Medical Officer

2021

Cynthia Seidel-Dugan

Werewolf Therapeutics

Chief Scientific Officer

News

In-depth

You may also like